Ascites is the buildup of fluid in the abdominal cavity, which often develops as a complication of liver disease. However, ...

Lindis Biotech has licensed Korjuny (catumaxomab) to Pharmanovia for malignant ascites, offering a targeted immune therapy ...

J Gastroenterol Hepatol. 2009;24(9):1494-1503. With the application of molecular approaches, efforts towards measuring the bacterial load using DNA in SBP patients have recently been made ...

Bedrest has traditionally been recommended for patients with ascites on the basis that upright posture increases aldosterone levels, which is associated with sodium retention. [11] Although ...

Ascites can develop in patients with cirrhosis as a result of disturbed fluid and electrolyte balance. Not all patients with ascites respond to spironolactone, which is the standard treatment for ...

Ascites is the most common complication of cirrhosis and a major cause of morbidity and hospitalization. Treatment of ascites is initially based on diuretics, but randomized studies assessing the ...